bioAffinity Technologies, Inc. Common Stock (BIAF) is a publicly traded Healthcare sector company. As of May 21, 2026, BIAF trades at $1.66 with a market cap of $7.64M and a P/E ratio of -0.24. BIAF moved -2.94% today. Year to date, BIAF is +32.80%; over the trailing twelve months it is -81.06%. Its 52-week range spans $0.69 to $67.12. Rallies surfaces BIAF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own BIAF include Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for bioAffinity Technologies, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $1.66 |
| Market Cap | $7.64M |
| P/E Ratio | -0.24 |
| EPS | $-6.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $67.12 |
| 52-Week Low | $0.69 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.66M |
| Net Income | $-15.88M |
| Gross Margin | 0.00% |
BIAF analyst coverage data. Average price target: $0.00.